No Active Intervention.
BehavioralConventional Chronic Disease Management in Malaysia Primary Care
Other names: Control
NCT Number: NCT00490672
Randomized controlled trial of CORFIS Programme.
The study objectives are as follows:
1. To determine the efficacy of a community based multiple risk factors interventional strategy (CORFIS) for a treatment period of 6 months in patients on treatment for HT, DM or HL. 2. The intervention shall consist of a purpose design and systematically organized disease management program that employ multi-faceted interventions incorporating various specific measures to maximize both clinician (as investigator) adherence with treatment guideline and patient adherence with treatment.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 4
Klinik Dr Khalil, Kuala Lumpur, Federal Territoy, Malaysia
It should be obvious to all that we urgently need to improve the management of the various risk factors for cardiovascular (CVD) and chronic kidney diseases (CKD); the 3 most important of which are Hypertension (HT), Diabetes mellitus (DM), Hyperlipidaemias (HL). It is not just that these are highly prevalent in our community, they are also poorly managed and controlled, with resulting highly costly and adverse health impact on our population. It should also be equally obvious that we need a better approach to manage these risk factors in our community. There have been considerable advances in our understanding of these risk factors and in our knowledge of the variety of approaches to achieving control of these risk factors including the role of self-monitoring and self-management education, medical nutrition therapy, physical activity, psychological counseling, and various drug therapy options.
This study is a multi-center, open label, parallel group randomized trial designed to demonstrate the effectiveness of a community based multiple risk factors interventional strategy (CORFIS).
750 patients on treatment for HT, DM or HL from 75 general practices (GPs) who meet inclusion/exclusion criteria will be enrolled into the trial. Among the 75 selected GPs, 50 of them will be randomly allocated to CORFIS and 25 to routine care.
After initial screening, patients will attend clinic for baseline examination. Study prescribed visits for efficacy and safety assessments will occur monthly for 6 months. Hence there will be a total of 7 visits.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Conventional Chronic Disease Management in Malaysia Primary Care
Other names: Control
Multi-faceted Intervention in Chronic Diseases Management i.e. Hypertension, Diabetes Mellitus, Hyperlipidaemia involving Primary Health Care Physicians, Nurse Educators, Dieticians and Pharmacists.
Other names: CORFIS
Time frame: 6 months follow up
Time frame: 6 months follow up
Ministry of Health, Malaysia
Other Gov
Community Based Multiple Risk Factors Intervention Strategy to Prevent Cardiovascular and Chronic Kidney Diseases [CORFIS]
Acronym: CORFIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04977583
Cardiovascular Disease, Cardiovascular Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT02593032
Cardiovascular Diseases, Diabetes Mellitus
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT00308386
Cardiovascular Diseases, Diabetes Mellitus
Hershey, Pennsylvania, United States
View Trial DetailsNCT00381992
Acquired Immunodeficiency Syndrome, Bacterial Infections
Winston-Salem, North Carolina, United States
View Trial Details